ArticleVeterinary medicine and science2026
Antibacterial Efficacy of 6-Gingerol Alone and in Combination With Enrofloxacin Against Multidrug-Resistant Staphylococcus aureus Isolated From Goats.
Article in Veterinary medicine and science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundGoat mastitis is an economically important disease that reduces milk yield and quality while also posing a public health risk due to antimicrobial-resistant pathogens.
objectivesThis study aimed to evaluate mastitis diagnostic techniques, isolate Staphylococcus aureus, detect methicillin-resistant S. aureus (MRSA) and assess the antibacterial potential of 6-gingerol alone and in combination with antibiotics.
methodsA total of 2000 aseptically collected milk samples were obtained from lactating goats presented at the Civil Veterinary Hospital, Chargano Chowk and the Veterinary Teaching Hospital, The University of Agriculture Peshawar, Pakistan. Samples were screened using the Surf Field Mastitis Test and confirmed by the California Mastitis Test (CMT). Positive samples were cultured on selective media, and S. aureus was identified through Gram staining, catalase and coagulase tests. MRSA detection was performed using PCR amplification of the mecA gene. Antimicrobial susceptibility was assessed using the Kirby-Bauer disc diffusion method according to CLSI guidelines. The antibacterial activity of standard and extracted 6-gingerol, selected antibiotics and enrofloxacin plus 6-gingerol combination therapy was evaluated using inhibition zone diameter and minimum inhibitory concentration (MIC) assays.
resultsThe Surf Field Mastitis Test showed high diagnostic performance with excellent sensitivity, moderate specificity and substantial agreement with the CMT. S. aureus isolates exhibited varying resistance patterns, with confirmed presence of MRSA strains via mecA gene detection. Among treatments, enrofloxacin demonstrated the highest individual antibacterial activity, while extracted 6-gingerol showed moderate inhibitory effects. The combination of enrofloxacin with 6-gingerol exhibited the strongest antibacterial activity, surpassing all single-agent treatments. MIC analysis confirmed a concentration-dependent inhibitory effect of 6-gingerol against S. aureus. Correlation analysis showed a strong negative relationship between increasing compound concentration and bacterial growth, while combination therapy significantly enhanced antimicrobial efficacy.
conclusionThese findings demonstrate that rapid field diagnostics are effective for mastitis screening and suggest that 6-gingerol, particularly in combination with enrofloxacin, may serve as a promising adjunct antimicrobial strategy for controlling resistant S. aureus in goat mastitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.